A correlation between membrane glycopeptide composition and losses in concanavalin a agglutinability induced by db-cAMP in Chinese hamster ovary cells

A double-label method, employing [¹⁴C]- and [³H]-fucose, has been used to compare the carbohydrate components of surface glycoproteins from four different sub-clones of Chinese hamster ovary cells grown in the presence or absence of either 3′: 5′-dibutyryl cyclic AMP (db-cAMP), 3′: 5′-cyclic AMP (cAMP) or a phosphodiesterase inhibitor SQ 20009. Following growth in one or more of these drugs, a number of these sub-clones showed a fairly small, but consistent reduction in the amount of the more rapidly eluting fucopeptides that could be isolated from the plasma membrane and a corresponding increase in lower molecular weight components as determined by Sephadex G-50 chromatography. This apparent decrease in the size of surface fucopeptides was related to a reduced sialic acid content of a class of surface glycopeptides isolated from the treated cells. This surface change was always correlated with a loss of concanavalin A (ConA)-mediated agglutinability. However, this surface change was not invariably associated with the drug-induced morphological transition towards a more fibroblast-like form. More-over, the sialic acid-rich glycopeptides bound only poorly to ConA affinity columns and were probably not therefore the lectin receptors. Double-label experiments have shown that upon addition of db-cAMP to the cells, existing glycopeptides are apparently unmodified but rather new components reaching the cell surface have a reduced amount of sialic acid associated with them. We propose that the loss in lectin-induced agglutinability and the reduction in glycopeptide size are related phenomena resulting from a primary change in cell surface chemistry.